Guidelines

Links to national and related international guidelines and documentation relevant to the management of Hepatitis B are provided below for further reading.

 

The Green Book: Immunisations. Updated September 2012

Department of Health Guidance on immunisation against infectious diseases - including Hepatitis B.

 

European Association for the Study of the Liver (EASL) Clinical Practice Guidelines: Management of chronic Hepatitis B

The objective of these EASL Clinical Practice Guidelines (CPGs) is to update recommendations
for the optimal management of chronic Hepatitis B (CHB).

 

NICE Technology Appraisal Guidance no.96: Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic Hepatitis B

Guidance published in 2006 by the National Institute for Health and Clinical Excellence (NICE), including a quick reference guide and information for patients.

 

NICE Technology Appraisal Guidance no.153: Entecavir for the treatment of chronic Hepatitis B

Guidance published in 2008 by the National Institute for Health and Clinical Excellence (NICE), including a quick reference guide and information for patients.

 

NICE Technology Appraisal Guidance no. 173: Tenofovir disoproxil for the treatment of chronic Hepatitis B

Guidance published in 2009 by the National Institute for Health and Clinical Excellence (NICE), including a quick reference guide and information for patients.

 

NICE Public Health Guidance no. 21: Reducing differences in the uptake of immunisations (including targeted vaccines) among children and young people aged under 19 years

Guidance published in 2009 by the National Institute for Health and Clinical Excellence, including improving uptake of the Hepatitis B immunisation for babies born to mothers infected with Hepatitis B.

 

NICE Public Health Guidance no. 43: Hepatitis B and C: Ways to promote and offer testing to people at increased risk of infection

Guidance published in 2012 by the National Institute for Health and Clinical Excellence (NICE) on ways to promote and offer testing to people at increased risk of Hepatitis B and C infection.

 

NICE Clinical Guideline no 165: Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B

in children, young people and adults


Guidance issued in June 2013 by the National Institute for Health and Clinical Excellence (NICE) on diagnosis and management of chronic Hepatitis B.

 

NICE Public Health Guidance 52: Needle and Syringe Programmes

Updated guidance published in March 2014 by the National Institute for Health and Clinical Excellence (NICE) on needle and syringe exchange programmes including those provided by pharmacies and drug services for adults and young people (including those under 16) who inject drugs, including image and performance enhancing drugs.

 

Dept of Health Hepatitis B antenatal screening and newborn immunisation programme

2011 best practise guidance on antenatal screening and newborn immunisation for Hepatitis B.

 

Scottish Medicines Consortium: Advice on tenofovir disoproxil (as fumarate) in treatment of chronic Hepatitis B in adults with decompensated liver disease.

Advice published in 2011 by the Scottish Medicines Consortium. 

 

 Guidelines for the prevention, care and treatment of persons with chronic Hepatitis B infection

 

International guidelines published by the World Health Organisation on the prevention, care and treatment of those with chronic Hepatitis B infection. 

 

 

 

 

Find Support in Scotland

Search for Hepatitis B services in
your area.
Find out more 

Sexual Health and Blood Borne Virus Framework

The Scottish Government has published the Sexual Health and Blood Borne Virus Framework to tackle Hepatitis B in Scotland.
> Download Framework